Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Intravascular Lithotripsy vs Super-High-Pressure Noncompliant Balloons for Treatment of Calcified Coronary Lesions: The VICTORY Trial
Matthias Bossard; Tej Sheth; Natalia Pinilla; Adrian Attinger-Toller; Giacomo Cioffi; Alessandro Spirito; Tobias Göldi; Matt Sibbald; Jorge Carrillo; Yuan Zhi; Leah Stutz; Mehdi Madanchi; Diego Arroyo; Federico Moccetti; Mathias Wolfrum; Stefan Toggweiler; Monika Röthlin; Lukasz Partyka; Wojciech Szada; Aleksander Galas; Virginia Justi; Sanjit S. Jolly; Florim CuculiShow moreShow less
Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland; Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland; Division of Cardiology, Hamilton General Hospital, Hamilton, Ontario, Canada; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Cardiologie Hôpital Fribourgeois (HFR), Hôpital Cantonal Fribourg, Fribourg, Switzerland; Cardiology Division, Hôpital de La Tour, Meyrin, Switzerland; KCRI, Kraków, Poland; Department of Angiology, University Hospital of Kraków, Kraków, Poland; Department of Cardiology, University Hospital of Kraków, Kraków, Poland; Jagiellonian University Medical College, Department of Epidemiology and Preventive Medicine, Kraków, PolandShow moreShow less
Early Discharge Strategy Including Subcutaneous Furosemide in Hospitalized Heart Failure
Ross T. Campbell; Joanna Osmanska; Kieran F. Docherty; Fozia Z. Ahmed; Andrew L. Clark; Louise Clayton; John G.F. Cleland; Christopher Critoph; Matthew Dewhurst; Nick Hartshorne-Evans; Roy S. Gardner; Kate Gatenby; Kaushik Guha; Colette E. Jackson; Paul Kalra; Andrea Lees; Kirsty Martin; Liane McGlynn; Kirstie Mowat; Pieter Muntendam; Joanne O’Donnell; Anna Placzek; Colum Owens; Robin Ray; Henry O. Savage; Rebekah Schiff; Iain Squire; Chih Wong; Ken Wong; Alex McConnachie; John J.V. McMurray; Mark C. PetrieShow moreShow less
School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom; Queen Elizabeth University Hospital, Glasgow, United Kingdom; Glasgow Royal Infirmary, Glasgow, United Kingdom; Department of Cardiology, Manchester University NHS Foundation Trust, Manchester, United Kingdom; Keele Cardiovascular Research Group, Keele University, Keele, United Kingdom; Hull York Medical School, University of Hull, Hull, United Kingdom; Glenfield Hospital, Leicester, United Kingdom; University of Dorset NHS Foundation Trust, Dorset, United Kingdom; Northumbria Healthcare NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; Pumping Marvellous Foundation, Preston, United Kingdom; Golden Jubilee National Hospital, Glasgow, United Kingdom; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom; Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom; Robertson Centre for Biostatistics, School of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom; SQ Innovation Inc., Burlington, Massachusetts, USA; Belfast Health & Social Care Trust, Belfast, United Kingdom; St George's Healthcare NHS Trust, London, United Kingdom; Essex Cardiothoracic Centre, Basildon, United Kingdom; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Southmead Hospital, Bristol, United Kingdom; Lancashire Cardiac Centre, Blackpool, United Kingdom; and the u Keele Cardiovascular Research Group, Keele University, Keele, United KingdomShow moreShow less
Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B
Yasuhiro Hamatani; Brian L. Claggett; Sarah A.M. Cuddy; Nitasha Sarswat; Joban Vaishnav; Martha Grogan; Mathew S. Maurer; Ronald M. Witteles; Esther Gonzalez-Lopez; Pablo Garcia-Pavia; Farooq H. Sheikh; Brian M. Drachman; Alisa Kosheleff; Sameer Bansilal; Julian D. Gillmore; Marianna Fontana; Scott D. SolomonShow moreShow less
Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; National Hospital Organization Kyoto Medical Center, Kyoto, Japan; Division of Cardiovascular Medicine, University of Chicago Medicine, Chicago, Illinois, USA; Johns Hopkins Hospital, Baltimore, Maryland, USA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA; Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA; Stanford University School of Medicine, Stanford, California, USA; Hospital Universitario Puerta de Hierro Majadahonda, IDIPHIM, CIBERCV, and Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain; MedStar Heart and Vascular Institute/Georgetown University School of Medicine, Washington, DC, USA; Penn Presbyterian Medical Center, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA; Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA; National Amyloidosis Centre, UCL, Division of Medicine, Royal Free Hospital, London, United KingdomShow moreShow less
Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis
Arielle Abovich; Marianna Fontana; Brian Claggett; Julian D. Gillmore; Francesco Cappelli; Amrut V. Ambardekar; Caroline Morbach; Pablo Garcia-Pavia; Ronald M. Witteles; Mathew S. Maurer; Patrick Y. Jay; Alisa Kosheleff; Sameer Bansilal; Scott D. SolomonShow moreShow less
Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom; Bis Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy; Tuscan Amyloidosis Referral Center Careggi University Hospital, Florence, Italy; Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA; Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany; Department of Medicine I, University Hospital Würzburg, Würzburg, Germany; Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Health Research Institute of the Puerta de Hierro Majadahonda-Segovia de Arana, Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBER-CV), and Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA; Columbia University Irving Medical Center, New York, New York, USA; Alnylam Pharmaceuticals, Cambridge, Massachusetts, USAShow moreShow less
Outcomes After Lymphatic Embolization for Protein-Losing Enteropathy in Congenital Heart Disease
Christopher L. Smith; Ari J. Gartenberg; Brooke Ford; Ganesh Krishnamurthy; Abhay Srinivasan; Fernando A. Escobar; Mudit Gupta; Jefferson N. Brownell; Petar Mamula; David Goldberg; Chitra Ravishankar; Aaron G. Dewitt; Danish Vaiyani; David M. Biko; Erin M. Pinto; Pablo Laje; Katsuhide Maeda; Matthew J. Gillespie; Michael L. O’Byrne; Jie Tang; Ryan Callahan; Jonathan J. Rome; Yoav DoriShow moreShow less
Jill and Mark Fishman Center for Lymphatic Disorders, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Division of Cardiology, The Children's Hospital of Philadelphia and Department of Pediatrics Perelman School of Medicine at The University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Radiology, The Children's Hospital of Philadelphia and Perelman School of Medicine at The University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Gastroenterology, The Children's Hospital of Philadelphia and Department of Pediatrics Perelman School of Medicine at The University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Surgery, The Children's Hospital of Philadelphia and Perelman School of Medicine at The University of Pennsylvania, Philadelphia, Pennsylvania, USAShow moreShow less
Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure (TARTAN-HF)
Daniel Taylor-Sweet; Mark C. Petrie; Gemma McKinley; Liane McGlynn; John Jarvie; Jack Beazer; Elaine Butler; Ellen MacDonald; Paul Welsh; Michelle Martinson; Katriona Brooksbank; Anna Barnett; John Kerr; Colin J. Petrie; Robin A.P. Weir; Sasha T. Gold; Lesley Hall; Brian Kennon; Andrea Llano; Gerard McKay; Maroria Oroko; Malbinder Fagura; Elmas Malvolti; Naveed Sattar; Ross T. Campbell; Alex McConnachie; John J.V. McMurray; Carolyn S.P. Lam; Kieran F. DochertyShow moreShow less
BHF Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom; Robertson Centre for Biostatistics, School of Health and Wellbeing, University of Glasgow, Glasgow, Scotland, United Kingdom; NHS Greater Glasgow and Clyde Research and Innovation, Glasgow, Scotland, United Kingdom; NHS Research Scotland, Diabetes Network and School of Medicine, University of Dundee, Dundee, Scotland, United Kingdom; University Hospital Monklands, NHS Lanarkshire, Airdrie, Scotland, United Kingdom; University Hospital Hairmyres, NHS Lanarkshire, East Kilbride, Scotland, United Kingdom; Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom; Glasgow Royal Infirmary, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom; Vale of Leven Hospital, NHS Greater Glasgow and Clyde, Alexandria, Scotland, United Kingdom; AstraZeneca, Cambridge, United Kingdom; National Heart Centre Singapore & Duke-NUS Graduate Medical School Singapore, SingaporeShow moreShow less
FAQ
How long does JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. The fastest paper went from submission to acceptance in 28 days (Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B, received 2026-06-22, accepted 2026-07-20); the slowest took 363 days. The average is 121.4 days and the median is 92.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
